State of Wisconsin Investment Board’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.5M Sell
135,798
-750
-0.5% -$332K 0.14% 113
2026
Q1
$61M Sell
136,548
-1,361
-1% -$635K 0.14% 117
2025
Q4
$62.5M Sell
137,909
-10,440
-7% -$4.5M 0.14% 113
2025
Q3
$58.1M Buy
148,349
+5,411
+4% +$2.26M 0.13% 118
2025
Q2
$63.6M Sell
142,938
-9,739
-6% -$4.49M 0.16% 106
2025
Q1
$74M Buy
152,677
+437
+0.3% +$204K 0.19% 94
2024
Q4
$61.3M Sell
152,240
-1,939
-1% -$899K 0.16% 106
2024
Q3
$71.7M Buy
154,179
+4,925
+3% +$2.37M 0.18% 94
2024
Q2
$70M Sell
149,254
-12,708
-8% -$5.52M 0.18% 100
2024
Q1
$67.7M Buy
161,962
+3,974
+3% +$1.68M 0.18% 106
2023
Q4
$64.3M Sell
157,988
-1,643
-1% -$607K 0.18% 108
2023
Q3
$55.5M Sell
159,631
-20,728
-11% -$7.25M 0.17% 115
2023
Q2
$63.5M Buy
180,359
+10,377
+6% +$3.5M 0.18% 121
2023
Q1
$53.6M Sell
169,982
-1,520
-0.9% -$456K 0.16% 130
2022
Q4
$49.5M Sell
171,502
-7,591
-4% -$2.31M 0.16% 133
2022
Q3
$51.9M Sell
179,093
-41,856
-19% -$12M 0.16% 118
2022
Q2
$62.3M Sell
220,949
-29,829
-12% -$7.98M 0.16% 120
2022
Q1
$65.4M Buy
250,778
+43,978
+21% +$10.4M 0.14% 137
2021
Q4
$45.4M Sell
206,800
-62,201
-23% -$12.1M 0.09% 249
2021
Q3
$48.8M Sell
269,001
-155,828
-37% -$30.4M 0.1% 225
2021
Q2
$85.7M Buy
424,829
+137,996
+48% +$28.9M 0.18% 135
2021
Q1
$61.6M Sell
286,833
-66,713
-19% -$14.7M 0.13% 178
2020
Q4
$83.6M Buy
353,546
+2,746
+0.8% +$630K 0.19% 116
2020
Q3
$95.5M Sell
350,800
-8,291
-2% -$2.29M 0.24% 92
2020
Q2
$104M Buy
359,091
+149,809
+72% +$40.6M 0.29% 71
2020
Q1
$49.8M Sell
209,282
-36,963
-15% -$8.48M 0.17% 133
2019
Q4
$53.9M Sell
246,245
-16,118
-6% -$3.26M 0.14% 164
2019
Q3
$44.5M Sell
262,363
-82,941
-24% -$14.7M 0.12% 182
2019
Q2
$63.3M Sell
345,304
-28,701
-8% -$5.02M 0.18% 125
2019
Q1
$68.8M Buy
374,005
+47,755
+15% +$8.82M 0.2% 106
2018
Q4
$54.1M Buy
326,250
+23,680
+8% +$4.1M 0.18% 122
2018
Q3
$58.3M Sell
302,570
-11,629
-4% -$2.07M 0.16% 126
2018
Q2
$53.4M Buy
314,199
+50,990
+19% +$7.9M 0.15% 138
2018
Q1
$42.9M Sell
263,209
-14,161
-5% -$2.31M 0.12% 171
2017
Q4
$41.6M Buy
277,370
+56,936
+26% +$8.43M 0.11% 193
2017
Q3
$33.5M Sell
220,434
-147,897
-40% -$22.3M 0.1% 228
2017
Q2
$47.5M Buy
368,331
+177,510
+93% +$21.4M 0.15% 147
2017
Q1
$20.9M Buy
190,821
+67,257
+54% +$5.92M 0.08% 277
2016
Q4
$9.1M Buy
123,564
+56,989
+86% +$4.64M 0.04% 506
2016
Q3
$5.81M Sell
66,575
-97,500
-59% -$9.21M 0.02% 719
2016
Q2
$14.1M Sell
164,075
-99,220
-38% -$8.57M 0.06% 376
2016
Q1
$20.9M Buy
263,295
+2,750
+1% +$249K 0.08% 272
2015
Q4
$32.8M Buy
260,545
+98,470
+61% +$11.9M 0.13% 178
2015
Q3
$16.9M Buy
162,075
+10,980
+7% +$1.41M 0.07% 350
2015
Q2
$18.7M Buy
151,095
+7,740
+5% +$975K 0.07% 352
2015
Q1
$16.9M Sell
143,355
-4,910
-3% -$588K 0.06% 386
2014
Q4
$17.6M Sell
148,265
-25,480
-15% -$2.87M 0.06% 371
2014
Q3
$19.5M Buy
173,745
+1,170
+0.7% +$111K 0.07% 337
2014
Q2
$16.3M Sell
172,575
-147,164
-46% -$10.3M 0.06% 399
2014
Q1
$22.6M Sell
319,739
-26,360
-8% -$2.09M 0.09% 279
2013
Q4
$25.7M Sell
346,099
-8,322
-2% -$580K 0.1% 240
2013
Q3
$26.9M Buy
354,421
+125,780
+55% +$10M 0.11% 214
2013
Q2
$18.3M Buy
+228,641
New +$16.8M 0.08% 315

Other funds holding VRTX

State of Wisconsin Investment Board's VRTX Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Vertex Pharmaceuticals (VRTX) stake by 0.55% in Q2 2026, selling an estimated $332K and leaving 135,798 shares worth $67.5M. The position accounts for 0.14% of the portfolio, ranked #113.

State of Wisconsin Investment Board first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $104M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • State of Wisconsin Investment Board held 135,798 shares of Vertex Pharmaceuticals worth $67.5M as of Q2 2026.
  • State of Wisconsin Investment Board sold 750 Vertex Pharmaceuticals shares in Q2 2026, an estimated $332K.
  • Vertex Pharmaceuticals made up 0.14% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #113 holding.
  • State of Wisconsin Investment Board first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • State of Wisconsin Investment Board's Vertex Pharmaceuticals position peaked at $104M in Q2 2020.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.